Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: A retrospective case-control study in the Nordic countries

Bone Marrow Transplantation

Volumn 17, Issue 3, 1996, Pages 357-363

  Saarinen, U M ^a   Mellander, L ^b   Nysom, K ^c   Ringden, O ^d   Schroeder, H ^e   Glomstein, A ^f   Gustafsson, G ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e AARHUS UNIVERSITY   (Denmark)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

1st remission; ALL; BMT

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DATA BASE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SIBLING; SURVIVAL; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; EVALUATION STUDIES; FEMALE; FINLAND; HUMANS; ICELAND; INCIDENCE; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SCANDINAVIA; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0030057933     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Steinherz PG, Gaynon P, Miller DR et al. Improved diseasefree survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen - a new intensive therapy protocol: a report from the Childrens Cancer Study Group. J Clin Oncol 1986; 4: 744-752.
2. Schorin MA. Blattner S, Gelber RD et al. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer institute/Children's Hospital acute lymphoblastic leukemia consortium protocol 85-01. J Clin Oncol 1994; 12: 740-747.
3. Pui CH, Crist WM. Biology and treatment of acute lymphoblastic leukemia. J Pediatr 1994; 124: 491-503.
4. Reiter A, Schrappe M, Ludwig WD et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84: 3122-3133.
5. Gustafsson G, Garwicz S, Hertz H et al. A population-based study of children with acute lymphoblastic leukemia in five Nordic countries diagnosed July 1981 through June 1985. Incidence, characteristics, and treatment results. Acta Paediatr Scand 1987; 76: 781-788.
6. Gustafsson G, Berglund G. Garwicz S et al. A populationbased study of children with standard risk acute lymphoblastic leukemia in the five Nordic countries. Acta Paediatr Scand 1989; 78: 104-109.
7. Lie S, Gustafsson G, Progress in the treatment of childhood leukemias. Ann Med 1992; 24: 319-323.
8. Rivera GK, Buchanan G, Boyett JM et al. Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group study. New Engl J Med 1986; 315: 273-278.
9. Herzig RH, Bortin MM, Barrett AJ et al. Bone marrow transplantation in high-risk acute lymphoblastic leukemia in first and second remission? Lancet 1987; i: 786-789.
10. Blume KG, Forman SF, Snyder DS et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission. Transplantation 1987; 43: 389-392.
11. Chao NJ, Forman SJ, Schmidt GM et al. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. Blood 1991; 78: 1923-1927.
12. Snyder DS, Chao NJ, Amylon MD et al. Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood 1993; 82: 2920-2928.
13. Sebban C. Lepage E. Vernant JP et al. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. J Clin Oncol 1994; 12: 2580-2587.
14. Bordigoni P, Vernant JP, Souillet G et al. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: a cooperative study of the Groupe d'Etude de la Greffe de Moelle Osseuse. J Clin Oncol 1989; 7: 747-753.
15. Schaison G, Bordigoni P, Leblanc T et al. Comparison of bone marrow transplantation (BMT), autologous BMT (ABMT). augmented chemotherapy (AC), in first complete remission (CR1) in children with very increased risk acute lymphoblastic leukemias (VIRCALL). Proc Am Soc Clin Oncol 1993; 12: 316 (abstr. 1043).
16. Chessels JM, Bailey C. Wheeler K, Richards SM. Bone marrow transplantation for high-risk childhood lymphoblastic leukemia in first remission: experience in MRC UKALL X. Lancet 1992; 340; 565-568.
17. Ringden O, Bolme P, Lönnqvist B et al. Bone marrow transplantation in children. Clin Transplant 1989; 3: 12-18.
18. Norusis MJ. SPSS Statistical Software. SPSS Inc: Chicago. IL, 1992.
19. Lee ET. Statistical Methods for Survival Data Analysis. John Wiley: New York, 1992.
20. Horowitz MM, Przepiorka D, Champlin RE et al. Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? Blood 1992; 79: 2771-2774.
21. Horowitz MM, Messerer D, Hoelzer D et al. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann intern Med 1991; 115: 13-18.
22. Kersey JH, Weisdorf D, Nesbit ME et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high risk refractory acute lymphoblastic leukemia. New Engl J Med 1987; 317: 461-467.
23. Brochstein JA, Keman NA, Groshen S et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. New Engl J Med 1987; 317: 1618-1624.
24. Sanders JE, Thomas ED, Buckner CD et al. Marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 1987; 70: 324-326.
25. Coccia PF, Strandjord SE, Warkentin PI et al. High-dose cytosine-arabinoside and fractionated total body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission. Blood 1988; 71: 888-893.
26. Dopfer R, Henze G, Bender-Gotze C et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German cooperative study. Blood 1991; 78: 2780-2784.
27. Ringden O, Bolme P, Lönnqvist B et al. Allogeneic bone marrow transplantation versus chemotherapy in children with acute leukemia in Sweden. Pediatr Hematol Oncol 1989; 6: 137-144.
28. Schroeder H, Saarinen U, Meilander L et al. Allogen BMT hos barn med ALL i NOPHO 1981-1991. Preliminaer rapport fra NOPHO's BMT gruppe (abstract). Annual meeting of the Nordic Society for Pediatric Hematology and Oncology (NOPHO), Lund, Sweden, April 1994.
29. Pihkala J, Saarinen UM, Lundström U et al. Effects of bone marrow transplantation on myocardial function in children. Bone Marrow Transplant 1994; 13: 149-155.
30. Chessels JM, Leiper AD, Plowman PN et al. Bone marrow transplantation has a limited role in prolonging second marrow remission in childhood lymphoblastic leukemia. Lancet 1986; i: 1239-1241.
31. Pinkel D. Bone marrow transplantation in children. J Pediatr 1993; 122: 331-341.
32. Reaman G, Zeltzer P, Bleyer WA et al. Acute lymphoblastic leukemia in infants less than 1 year of age: a cumulative experience of the Childrens Cancer Study Group. J Clin Oncol 1985; 33: 1513-1521.
33. Pui CH, Carroll AJ, Raimondi SC et al. Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid <45 line. Blood 1990; 75: 1170-1177.
34. Fletcher JA, Lynch EA, Kimball VM et al. Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 1991: 77: 435-439.
35. Pui C-H, Frankel LS, Carroll AJ et al. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leu-kemia with the t(4;11)(q21;q23): a collaborative study of 40 cases. Blood 1991; 77: 440-447.
36. Pui C-H. Behm FG, Downing JR et al. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol 1994; 12: 909-915.